A Study to Investigate the Effect of Food on Camlipixant Concentrations in Healthy Participants
Status:
COMPLETED
Trial end date:
2024-08-26
Target enrollment:
Participant gender:
Summary
This study is a single center, single dose, open-label, randomly assigned 2-way crossover study. The study will investigate the food effect on the pharmacokinetics of Camlipixant (GSK5464714) in healthy male and female participants. Eligible participants will be randomized to pre-defined sequences. There will be a washout of minimum 7 days between each dose of treatment period.